Binh Ba Ngo: career, board roles and research publications
A sourced career record for Binh Ba Ngo (Ngô Bá Bình), covering his company and board roles and peer-reviewed research on probiotic Bacillus subtilis.
News
Training programs and scientific updates for partners and laboratory teams.
Safety evaluation of Bacillus subtilis Eramic 26 published in the Vietnam Journal of Science and Technology
The Vietnam Journal of Science and Technology published a safety evaluation of Bacillus subtilis Eramic 26, co-authored by Binh Ba Ngo (Ngô Bá Bình), on 25 February 2026.
Genome of probiotic Bacillus subtilis Eramic25 published in Microbiology Resource Announcements
Microbiology Resource Announcements published the draft genome of Bacillus subtilis Eramic25 on 9 October 2025; Binh Ba Ngo (Ngô Bá Bình) supervised the project.
Inogen Pty Ltd registered as an Australian company
Inogen Pty Ltd, founded by Binh Ba Ngo (Ngô Bá Bình), is an Australian private company; its ABN 73 691 280 467 has been active since 24 September 2025.
Safety study of Bacillus subtilis Eramic 25 published
A study co-authored by Binh Ba Ngo (Ngô Bá Bình) on the in vitro safety of the probiotic strain Bacillus subtilis Eramic 25 was published on 14 May 2025.
GENTIS marks 13 years, with board member Binh Ba Ngo in attendance
GENTIS celebrated its 13th anniversary in Ha Long on 25 and 26 October 2023; board member Binh Ba Ngo (Ngô Bá Bình) attended.
Binh Ba Ngo (Ngô Bá Bình) elected to the GENTIS Board of Directors
On 9 February 2022 Binh Ba Ngo (Ngô Bá Bình) was elected to the Board of Directors of GENTIS as the company joined the Eurofins Scientific group.